MAM
Meeder Asset Management Portfolio holdings
AUM
$1.63B
1-Year Return
27.94%
This Quarter Return
+15.27%
1 Year Return
+27.94%
3 Year Return
+116.82%
5 Year Return
+187.4%
10 Year Return
+462.19%
AUM
$1.58B
AUM Growth
+$300M
(+23%)
Cap. Flow
+$158M
Cap. Flow
% of AUM
9.97%
Top 10 Holdings %
Top 10 Hldgs %
35.12%
Holding
822
New
356
Increased
160
Reduced
158
Closed
78
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$26.3M |
| 2 |
Johnson & Johnson
JNJ
|
$16.1M |
| 3 |
Lennar Class A
LEN
|
$15.9M |
| 4 |
Texas Instruments
TXN
|
$15.3M |
| 5 |
iShares Short Treasury Bond ETF
SHV
|
$13.3M |
Top Sells
| 1 |
Microsoft
MSFT
|
$30.1M |
| 2 |
AbbVie
ABBV
|
$21.1M |
| 3 |
Amgen
AMGN
|
$17.1M |
| 4 |
Adobe
ADBE
|
$16.9M |
| 5 |
UnitedHealth
UNH
|
$10.5M |
Sector Composition
| 1 | Technology | 27.78% |
| 2 | Financials | 14.74% |
| 3 | Consumer Discretionary | 11.75% |
| 4 | Industrials | 9.02% |
| 5 | Healthcare | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
626
Lennar Class B
LEN.B
$35.3B
| $5.4K | ﹤0.01% |
37
| – | – |
|
627
Curtiss-Wright
CW
$18.1B
| $5.38K | ﹤0.01% |
+21
| New | +$5.38K |
|
628
Carvana
CVNA
$50.9B
| $5.36K | ﹤0.01% |
+61
| New | +$5.36K |
|
629
Duolingo
DUOL
$12.4B
| $5.29K | ﹤0.01% |
+24
| New | +$5.29K |
|
630
Franklin Electric
FELE
$4.34B
| $5.13K | ﹤0.01% |
+48
| New | +$5.13K |
|
631
Jakks Pacific
JAKK
$196M
| $5.09K | ﹤0.01% |
206
| – | – |
|
632
ITT
ITT
$13.3B
| $5.03K | ﹤0.01% |
+37
| New | +$5.03K |
|
|
SWAV
633
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $4.88K | ﹤0.01% |
+15
| New | +$4.88K |
|
634
Simulations Plus
SLP
$279M
| $4.82K | ﹤0.01% |
+117
| New | +$4.82K |
|
635
Wabtec
WAB
$33B
| $4.81K | ﹤0.01% |
+33
| New | +$4.81K |
|
636
Vertiv
VRT
$47.4B
| $4.74K | ﹤0.01% |
+58
| New | +$4.74K |
|
637
Howmet Aerospace
HWM
$71.8B
| $4.72K | ﹤0.01% |
+69
| New | +$4.72K |
|
638
OGE Energy
OGE
$8.89B
| $4.67K | ﹤0.01% |
+136
| New | +$4.67K |
|
639
Elanco Animal Health
ELAN
$9.16B
| $4.62K | ﹤0.01% |
+284
| New | +$4.62K |
|
640
HEICO Class A
HEI.A
$35.1B
| $4.62K | ﹤0.01% |
+30
| New | +$4.62K |
|
641
Robinhood
HOOD
$90B
| $4.61K | ﹤0.01% |
+229
| New | +$4.61K |
|
642
Repligen
RGEN
$7.01B
| $4.6K | ﹤0.01% |
+25
| New | +$4.6K |
|
643
Tyson Foods
TSN
$20B
| $4.58K | ﹤0.01% |
+78
| New | +$4.58K |
|
644
Hubbell
HUBB
$23.2B
| $4.57K | ﹤0.01% |
11
-768
| -99% | -$319K |
|
645
Ennis
EBF
$476M
| $4.55K | ﹤0.01% |
+222
| New | +$4.55K |
|
646
Syndax Pharmaceuticals
SNDX
$1.47B
| $4.43K | ﹤0.01% |
+186
| New | +$4.43K |
|
647
Amicus Therapeutics
FOLD
$2.46B
| $4.41K | ﹤0.01% |
+374
| New | +$4.41K |
|
648
Clorox
CLX
$15.5B
| $4.29K | ﹤0.01% |
+28
| New | +$4.29K |
|
649
Veracyte
VCYT
$2.55B
| $4.28K | ﹤0.01% |
+193
| New | +$4.28K |
|
650
Sarepta Therapeutics
SRPT
$1.96B
| $4.27K | ﹤0.01% |
+33
| New | +$4.27K |
|